Published in Medical Devices and Surgical Technology Week, February 8th, 2004
The proposed study is a phase I/II escalating, single-dose, cohort trial in up to 50 patients with symptomatic advanced NSCLC and who are no longer responsive to conventional treatment. These patients will receive a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.